During clinical drug trials, phase II testing is performed on patients for whom the treatment is intended

Anaphylaxis is an extreme and life-threatening ________

a. autoimmune disease b. allergic response c. cancer d. birth defect

Reasonableness and ________________________ are the final determinants as to whether or not DME is covered by insurance

a. price b. supplier c. reusability d. necessity